Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins

Raymond R. Mattingly(Wayne State University)

ISRN Oncology

October 31, 2013

10.1155/2013/536529

Cited by 33

Related Papers

Three-Dimensional Overlay Culture Models of Human Breast Cancer Reveal a Critical Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibitors

|Journal of Pharmacology and Experimental Therapeutics|2009|76

Gβγ subunits stimulate p21‐activated kinase 1 (PAK1) through activation of PI3‐kinase and Akt but act independently of Rac1/Cdc42

|FEBS Letters|2003|24

Prolonged Mitogen-Activated Protein Kinase Kinase (MEK) Inhibition Induces Increase in Proteolysis and Compensatory Phosphorylation of MEK and Protein Kinase B (AKT) in Plexiform Neurofibroma Cells

|Cells|2026|0